Financhill
Buy
64

TSHA Quote, Financials, Valuation and Earnings

Last price:
$5.85
Seasonality move :
-17.85%
Day range:
$5.71 - $5.90
52-week range:
$1.05 - $6.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
259.98x
P/B ratio:
7.29x
Volume:
1.1M
Avg. volume:
3.6M
1-year change:
213.44%
Market cap:
$1.6B
Revenue:
$8.3M
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for TSHA
Feb 25
2026
Most recent earnings per share
-$0.09
Missed by $0.00
(Nov 4/2025)
Consensus Estimate
-$0.09
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TSHA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $1.9M -- -- -$0.10 --
11/04/2025 Q3 $1.4M -- -$0.09 -$0.09 -$0.00
08/12/2025 Q2 $1.6M $2M -$0.09 -$0.08 -$0.02
05/13/2025 Q1 $1.3M $2.3M -$0.08 -$0.09 $0.01
02/26/2025 Q4 $2.1M $2M -$0.09 -$0.10 $0.01
11/13/2024 Q3 $1.6M $1.8M -$0.10 -$0.09 -$0.01
08/12/2024 Q2 $2.6M $1.1M -$0.09 -$0.10 $0.01
05/14/2024 Q1 $2.3M $3.4M -$0.10 -$0.10 -$0.01
03/19/2024 Q4 $2.7M $3.6M $0.26 -$0.10 $0.35
11/14/2023 Q3 -- -- -$0.93 -$0.17 -$0.76
08/14/2023 Q2 -- -- -$0.38 -$0.31 -$0.07
05/11/2023 Q1 -- -- -$0.28 -$0.38 $0.10
03/28/2023 Q4 -- -- -$0.99 -$0.34 -$0.65
11/08/2022 Q3 -- -- -$0.64 -$0.82 $0.18
08/11/2022 Q2 -- -- -$0.84 -$1.06 $0.22
05/16/2022 Q1 -- -- -$1.31 -$1.11 -$0.21
03/31/2022 Q4 -- -- -$1.32 -$1.27 -$0.05
11/10/2021 Q3 -- -- -$1.35 -$1.09 -$0.26
08/16/2021 Q2 -- -- -$1.09 -$0.86 -$0.23
05/11/2021 Q1 -- -- -$0.87 -$0.65 -$0.22
03/03/2021 Q4 -- -- -$0.49 -$0.49 $0.01
11/12/2020 Q3 -- -- -$1.28 $0.07 -$1.35
06/30/2020 Q2 -- -- -$0.61 -- --
03/31/2020 Q1 -- -- -$0.36 -- --
12/31/2019 Q4 -- -- -$0.07 -- --

Taysha Gene Therapies, Inc. Earnings Questions

  • How Much did Taysha Gene Therapies, Inc. Generate in Revenue Last Quarter?

    Taysha Gene Therapies, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Taysha Gene Therapies, Inc. Beat Earnings Last Quarter?

    Taysha Gene Therapies, Inc. announced earnings per share of -$0.09 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Taysha Gene Therapies, Inc. Profitable?

    Taysha Gene Therapies, Inc. reported -$286K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Taysha Gene Therapies, Inc. EPS Next Year?

    Taysha Gene Therapies, Inc.'s earnings are forecast to decrease from -$0.36 per share to -$0.34 per share next year representing a decrease of -5.7%.

  • When is Taysha Gene Therapies, Inc.'s Earnings Date?

    Taysha Gene Therapies, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock